BIBF 1120 in Recurrent Glioblastoma Multiforme
This study has been completed.
Sponsor:
Ulrik Lassen
Collaborators:
Boehringer Ingelheim Pharmaceuticals
University of Copenhagen
Information provided by (Responsible Party):
Ulrik Lassen, Rigshospitalet, Denmark
ClinicalTrials.gov Identifier:
NCT01251484
First received: December 1, 2010
Last updated: October 3, 2012
Last verified: October 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | August 2012 |
| Primary Completion Date: | August 2012 (Final data collection date for primary outcome measure) |